Morgan Stanley’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
2020
Q4
$3.55M Buy
2020
Q3
$106K Sell
2020
Q2
$219K Buy
2020
Q1
$162K Sell
2019
Q4
$2.11M Buy
2019
Q3
$532K Buy
2019
Q2
$7K Sell
2019
Q1
$57K Sell
2018
Q4
$154K Sell
2018
Q3
$115K Buy
2018
Q2
$183K Buy